Home / Drug shortages / Methotrexate Sodium Injection

Methotrexate Sodium Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 03/13/2023.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
61703-408-41
Dosage Form
Injection
Presentation
Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)
Initial Posting
03/13/2023
Revised Date

FDA data resources